Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use DUOBRII safely and effectively. See full prescribing information for DUOBRII. DUOBRII® (halobetasol propionate and tazarotene) lotion, for topical useInitial U.S. Approval: 2019
Medication labelWhy this: Advisory · dailymed-prescription
DUOBRII® (halobetasol propionate and tazarotene) Lotion, 0.01%/0.045% is indicated for the topical treatment of plaque psoriasis in adults.
- generic_name
- halobetasol propionate and tazarotene
- product_names
- halobetasol propionate and tazarotene
- ndc
- 0187-0653, 0187-0653-01, 0187-0653-03
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en